Otezla Tabs Gain New Psoriasis Indication

Celgene announced that the Food and Drug Administration (FDA) has approved Otezla (apremilast) for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.

Will Tech Desensitize Doctors to Patient Suffering?

Technology may have the potential to expand treatment beyond the traditional means of healthcare (ie face-to-face visits), but are technologies distancing physicians from patients - namely, patient suffering?

Longevity Diminishes Quality of Life, Argues Controversial Essay

In a new controversial essay, bioethicist Dr. Ezekiel Emanuel argues that quality of life is often diminished with longevity (living ≥80 years of age).

Obesity, Endocrine Disruptors Linked to Early Puberty

In a recent opinion article, Dr. Laurence Steinberg describes the association between the obesity rate among children in the U.S. and the falling age of the onset of puberty.

FDA Launches Site to Warn Against Unlicensed Drug Distributors

The Food and Drug Administration (FDA) has launched "Know Your Source," an educational program to advise healthcare professionals and practice administrators on the purchasing of prescription drugs to protect patients from unsafe and ineffective medications.

Statins May Improve Hemorrhagic Stroke Outcomes

Patients taking statin medication while in the hospital for a hemorrhagic stroke are more than four times more likely to survive than people who aren't taking the drugs.

NIH Adds $10M to Encourage Gender Balance in Clinical Trials

The U.S. National Institutes of Health is investing $10 million in additional funding in scientific trials to encourage researchers to consider gender in their preclinical and clinical studies.

Ebola Cases Predicted to Continue Increasing

Based on data from the first nine months of the Ebola virus disease (EVD) epidemic, the numbers of cases are predicted to continue increasing, with the cumulative number of cases in Guinea, Liberia, Sierra Leone predicted to exceed 20,000 by November.

Chlamydia, Gonorrhea Screening for All Sexually Active Women, Says USPSTF

All sexually active women should be screened for two of the most common sexually transmitted infections: chlamydia and gonorrhea, according to new recommendations from the U.S. Preventive Services Task Force.

Behavioral Counseling for STI Reduction Advised

All sexually active adolescents and adults who are at increased risk for sexually transmitted infections should undergo "intensive" behavioral counseling to help prevent risky sexual behaviors (a B recommendation), according to the U.S. Preventive Services Task Force.